Levalbuterol Tartrate Hfa Inhalation recalls

Levalbuterol Tartrate Hfa Inhalation products have been recalled 2 times, most recently on 15 Jun 2022. The recalling company is usually Cardinal Health. The most common reason is manufacturing (cgmp) deviations.

Total recalls2since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 15 Jun 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why levalbuterol tartrate hfa inhalation is recalled

Manufacturing (CGMP) Deviations2100%

Companies

Product types

Inhalers & Asthma Medication2100%

By year

2022150%
2021150%

All levalbuterol tartrate hfa inhalation recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
15 Jun 2022Drug	CLASS II	Levalbuterol Tartrate HFA Inhalation Aerosol recalledLevalbuterol Tartrate Hfa Inhalation	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
2 Jun 2021Drug	CLASS II	Levalbuterol tartrate HFA Inhalation Aerosol recalled by Cardinal HealthLevalbuterol Tartrate Hfa Inhalation	Cardinal Health	Manufacturing (CGMP) Deviations	FL, GA, SC

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.